{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:33:34Z","timestamp":1790847214245,"version":"4.1.0"},"reference-count":56,"publisher":"EDP Sciences","issue":"3","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>La scl\u00e9rose en plaques (SEP) est une maladie du syst\u00e8me nerveux central \u00e0 composante inflammatoire, tr\u00e8s invalidante qui atteint g\u00e9n\u00e9ralement de jeunes adultes (20 \u00e0 40 ans). Cette maladie se caract\u00e9rise par la destruction progressive, par les cellules du syst\u00e8me immunitaire, de la gaine de my\u00e9line des axones, ce qui aboutit \u00e0 une d\u00e9g\u00e9n\u00e9rescence neuronale. Les lymphocytes T et B sont les acteurs principaux de cette maladie qui peut \u00eatre r\u00e9mittente ou progressive. Parmi les m\u00e9dicaments utilis\u00e9s dans le cadre de son traitement, le fingolimod, un immunosuppresseur dont les cibles sont les r\u00e9cepteurs de la sphingosine 1-phosphate, administr\u00e9 par voie orale, agit en emp\u00eachant les lymphocytes de quitter le thymus et les ganglions lymphatiques, et de rejoindre les foyers inflammatoires c\u00e9r\u00e9braux. Une recherche intense pour d\u00e9velopper des traitements et des m\u00e9dicaments curatifs est actuellement en cours et d\u2019autres immunosuppresseurs interagissant avec les r\u00e9cepteurs de sphingosine 1-phosphate sont en cours de d\u00e9veloppement.<\/jats:p>","DOI":"10.1051\/medsci\/2020026","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T08:17:01Z","timestamp":1585642621000},"page":"243-252","source":"Crossref","is-referenced-by-count":2,"title":["La scl\u00e9rose en plaques et les m\u00e9dicaments immuno-modulateurs des r\u00e9cepteurs de la sphingosine 1-phosphate"],"prefix":"10.1051","volume":"36","author":[{"given":"Franck","family":"Talmont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastassia","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3346-375X","authenticated-orcid":false,"given":"Olivier","family":"Cuvillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"R2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.neurol.2018.03.006","volume":"174","author":"Zephir","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"R3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-019-01980-7","volume":"137","author":"Brambilla","year":"2019","journal-title":"Acta Neuropathol"},{"key":"R4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.imlet.2014.11.001","volume":"163","author":"Cornaby","year":"2015","journal-title":"Immunol Lett"},{"key":"R5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"R6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"R7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"1756286419859722","DOI":"10.1177\/1756286419859722","volume":"12","author":"Cortese","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"R9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.nurt.2007.08.002","volume":"4","author":"Weber","year":"2007","journal-title":"Neurotherapeutics"},{"key":"R10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s13311-017-0557-4","volume":"14","author":"Gelfand","year":"2017","journal-title":"Neurotherapeutics"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1051\/medsci\/200925121113","volume":"25","author":"Papeix","year":"2009","journal-title":"Med Sci (Paris)"},{"key":"R12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2018.20588","volume":"321","author":"Brown","year":"2019","journal-title":"JAMA"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3389\/fimmu.2019.01564","volume":"10","author":"Rommer","year":"2019","journal-title":"Front Immunol"},{"key":"R14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13104-019-4507-6","volume":"12","author":"Holmoy","year":"2019","journal-title":"BMC Res Notes"},{"key":"R15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet"},{"key":"R16","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1161\/CIRCRESAHA.116.308929","volume":"119","author":"Gazit","year":"2016","journal-title":"Circ Res"},{"key":"R17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1172\/JCI76369","volume":"125","author":"Proia","year":"2015","journal-title":"J Clin Invest"},{"key":"R18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.tips.2018.08.006","volume":"39","author":"Blaho","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"R19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00018-005-5557-6","volume":"63","author":"Sarramegna","year":"2006","journal-title":"Cell Mol Life Sci."},{"key":"R20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygcen.2004.12.018","volume":"142","author":"Schioth","year":"2005","journal-title":"Gen Comp Endocrinol"},{"key":"R21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1051\/medsci\/20122811013","volume":"28","author":"Cuvillier","year":"2012","journal-title":"Med Sci (Paris)"},{"issue":"suppl 1","key":"R22","first-page":"S21","volume":"176","author":"Alexander","year":"2019","journal-title":"Br J Pharmacol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI10905","volume":"106","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"R24","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/ni1545","volume":"8","author":"Schwab","year":"2007","journal-title":"Nat Immunol"},{"key":"R25","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2174\/1389450116666151001112710","volume":"17","author":"Healy","year":"2016","journal-title":"Curr Drug Targets"},{"key":"R26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00210-014-0957-5","volume":"387","author":"Talmont","year":"2014","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"R27","doi-asserted-by":"crossref","first-page":"e0213203","DOI":"10.1371\/journal.pone.0213203","volume":"14","author":"Talmont","year":"2019","journal-title":"PLoS One"},{"key":"R28","doi-asserted-by":"crossref","first-page":"e46348","DOI":"10.1371\/journal.pone.0046348","volume":"7","author":"Talmont","year":"2012","journal-title":"PLoS One"},{"key":"R29","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1111\/febs.12446","volume":"280","author":"Adada","year":"2013","journal-title":"FEBS J"},{"key":"R30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2018.11.018","volume":"124","author":"Seyedsadr","year":"2019","journal-title":"Neurobiol Dis"},{"key":"R31","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1158\/0008-5472.CAN-09-1110","volume":"69","author":"Cattoretti","year":"2009","journal-title":"Cancer Res"},{"key":"R32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1523\/JNEUROSCI.4645-04.2005","volume":"25","author":"Jaillard","year":"2005","journal-title":"J Neurosci"},{"key":"R33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-9-133","volume":"9","author":"Van Doorn","year":"2012","journal-title":"J Neuroinflammation"},{"key":"R34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1096\/fj.03-0910fje","volume":"18","author":"Graler","year":"2004","journal-title":"FASEB J"},{"key":"R35","doi-asserted-by":"crossref","first-page":"9082","DOI":"10.1074\/jbc.M610318200","volume":"282","author":"Oo","year":"2007","journal-title":"J Biol Chem"},{"key":"R36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2017.11.001","volume":"185","author":"Huwiler","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/mol.115.100222","volume":"89","author":"Sanna","year":"2016","journal-title":"Mol Pharmacol"},{"key":"R38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/WCO.0000000000000692","volume":"32","author":"Kremer","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"R39","doi-asserted-by":"crossref","first-page":"e201800039","DOI":"10.26508\/lsa.201800039","volume":"1","author":"Sun","year":"2018","journal-title":"Life Sci Alliance"},{"key":"R40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nn1460","volume":"8","author":"Mi","year":"2005","journal-title":"Nat Neurosci"},{"key":"R41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol"},{"key":"R42","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1474-4422(19)30137-1","volume":"18","author":"Cadavid","year":"2019","journal-title":"Lancet Neurol"},{"key":"R43","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"R44","unstructured":"Bordet R, Camu W, De Seze J, et al. Mechanism of action of s1p receptor modulators in multiple sclerosis: the double requirement. Rev Neurol (Paris) 2019; Nov 19. pii: S0035\u20133787(18)30499\u20135."},{"key":"R45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-8-76","volume":"8","author":"Jackson","year":"2011","journal-title":"J Neuroinflammation"},{"key":"R46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-016-0612-9","volume":"13","author":"Szepanowski","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R47","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1096\/fj.10-173203","volume":"25","author":"Kim","year":"2011","journal-title":"FASEB J"},{"key":"R48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12974-016-0686-4","volume":"13","author":"Gentile","year":"2016","journal-title":"J Neuroinflammation"},{"key":"R49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","volume":"4","author":"Sedel","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"R50","doi-asserted-by":"crossref","unstructured":"Cuascut FX, Hutton GJ. Stem cell-based therapies for multiple sclerosis: current perspectives. Biomedicines 2019; 7.","DOI":"10.3390\/biomedicines7020026"},{"key":"R51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2018.18743","volume":"321","author":"Burt","year":"2019","journal-title":"Jama"},{"key":"R52","doi-asserted-by":"crossref","unstructured":"Kvistad SAS, Lehmann AK, Trovik LH, et al. Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. Mult Scler 2019 ; 1352458519893926 :","DOI":"10.1177\/1352458519893926"},{"key":"R53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaneurol.2016.5867","volume":"74","author":"Muraro","year":"2017","journal-title":"JAMA Neurol"},{"key":"R54","doi-asserted-by":"crossref","first-page":"116830","DOI":"10.1016\/j.lfs.2019.116830","volume":"235","author":"Mansoor","year":"2019","journal-title":"Life Sci"},{"key":"R55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13063-019-3346-z","volume":"20","author":"Uccelli","year":"2019","journal-title":"Trials"},{"key":"R56","first-page":"1","volume":"11","author":"Shroff","year":"2018","journal-title":"Stem Cells Cloning"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020026\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T18:53:08Z","timestamp":1595271188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2020026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":56,"journal-issue":{"issue":"3"},"alternative-id":["msc190224"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2020026","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}